Therefore, in line with the current understanding, glucocorticosteroids, adrenocorticotropic hormone (ACTH) and intravenous immunoglobulins are the most commonly used in OMS treatment following NT resection, which is an integral part of the treatment, albeit insufficient as a stand-alone procedure [1,2,3,4,5,6,7,14]. Here, POMC is linked to opsoclonus-myoclonus syndrome.